Cargando…
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Finding a long-term cure for tumor patients still represents a major challenge. Immunotherapies offer promising therapy options, since they are designed to specifically prime the immune system against the tumor and modulate the immunosuppressive tumor microenvironment. Using nucleic-acid-based vacci...
Autores principales: | Schunke, Jenny, Mailänder, Volker, Landfester, Katharina, Fichter, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419017/ https://www.ncbi.nlm.nih.gov/pubmed/37569548 http://dx.doi.org/10.3390/ijms241512174 |
Ejemplares similares
-
The challenges of oral drug delivery via nanocarriers
por: Reinholz, Jonas, et al.
Publicado: (2018) -
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
por: Brückner, Maximilian, et al.
Publicado: (2022) -
Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
por: Diao, Dingwei, et al.
Publicado: (2021) -
Silica Nanocapsules with Different Sizes and Physicochemical Properties as Suitable Nanocarriers for Uptake in T-Cells
por: Thiramanas, Raweewan, et al.
Publicado: (2020) -
Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
por: Thiramanas, Raweewan, et al.
Publicado: (2020)